Appropriate and Value-Based Care Conference 2025

16 October 2025

Event date: 16 October 2025 - 17 October 2025

The Appropriate and Value-Based Care (AVBC) Conference 2025 marks a significant milestone in Singapore's national efforts to embed value-based care across healthcare policy and practice.

Centred on the theme Maximising Value for All, the conference will spotlight how AVBC is being implemented across our health system—from policy and financing to clinical practice and patient engagement.

Participants will hear from international experts and local leaders on strategies that improve outcomes, optimise resources, and put patient needs at the centre of care. Through plenaries, workshops, and panels, the conference aims to catalyse system-wide dialogue and collaboration for the next phase of Singapore's healthcare transformation.

Registration for the AVBC Conference 2025 is not open yet. Submit your interest here to stay updated and be among the first to know when registration launches.

Call for Abstracts is Now Open!

We invite healthcare professionals and administrators from Singapore’s public healthcare and academic institutions to submit oral and poster abstracts for the MOH Appropriate and Value-Based Care (AVBC) Conference 2025, taking place on 16 and 17 October.

This year’s conference theme, “Maximising Value for All”, recognises the increasing importance of driving Appropriate and Value-Based Care in Singapore’s healthcare sector, emphasising the need for widespread adoption of this culture and mindset to unleash its transformational benefits.

Kindly click here to submit your abstracts.

Call for Abstract Timeline

Abstract Submissions Open	8th May 2025
Abstract Submissions Close	1st July 2025 1200hrs SGT
Notification to Authors of Shortlisted Abstracts	1st August 2025
Poster Presentation at the Conference Oral Presentation at the Conference	16th October 2025 17th October 2025

Abstract Categories

Overarching Abstract Theme: Embracing value-based care practices that improve health outcomes and transform healthcare delivery
AVBC Core Principles: Care is evidence-based: Care decisions are based on the best available, scientifically validated data. Standardised care decisions reduce variability in clinical outcomes. Care is patient-centred: Care is designed with the patient’s treatment goals in mind. Patient-centredness promotes patient activation through access to timely information and/or shared decision-making. Care is right-sited: Care is delivered in the most appropriate setting, balancing patient needs and cost-efficiency. Care is integrated and coordinated: Care is delivered in an organised manner that avoids duplication or overlaps in care. Care is cost-effective and sustainable: Data is collected and analysed for the objective assessment of cost- effectiveness. Resource management decision-making is primarily guided by the desired value it generates.
Category 1 – Health Services and Care Pathways	Category 2 – Health Technologies and Treatments
Share your initiatives that involve: the implementation of evidence-based guidelines for managing specific clinical condition(s); enhancements to operational efficiency (e.g. reducing wait times); use of communications and collaborations that improve care coordination/ transitions (e.g. interdisciplinary or across healthcare settings); care model/ service transformation; or innovative projects for quality and safety improvement. Primary focus: Service delivery models and care pathway improvements Key Requirement: Demonstrates measurable improvements in clinical and/or patient outcomes; and includes measurement of implementation costs Examples: Integrated care models End-to-end patient journey optimisation Implementation of Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs) Novel Value-Driven Care Approaches (e.g., ERAS)	Share your initiatives that demonstrate the positive impact of adopting clinically- and cost-effective health technologies (e.g. drugs, devices, diagnostics, interventions, or vaccines) to drive value-based care changes in healthcare delivery. Examples include prescribing behaviour to use only clinically effective and cost-effective health technologies. Primary focus: Implementation and impact of specific healthcare technologies (e.g., drugs, medical devices, diagnostics, interventions, or vaccines) Key Requirement: Demonstrates the positive impact of adopting clinically- and cost-effective health technologies to improve healthcare delivery Examples: Changes in prescribing behaviour to adopt clinically- and cost-effective health technologies

Overarching Abstract Theme:

Embracing value-based care practices that improve health outcomes and transform healthcare delivery

AVBC Core Principles:

Care is evidence-based: Care decisions are based on the best available, scientifically validated data. Standardised care decisions reduce variability in clinical outcomes.
Care is patient-centred: Care is designed with the patient’s treatment goals in mind. Patient-centredness promotes patient activation through access to timely information and/or shared decision-making.
Care is right-sited: Care is delivered in the most appropriate setting, balancing patient needs and cost-efficiency.
Care is integrated and coordinated: Care is delivered in an organised manner that avoids duplication or overlaps in care.
Care is cost-effective and sustainable: Data is collected and analysed for the objective assessment of cost- effectiveness. Resource management decision-making is primarily guided by the desired value it generates.

Category 1 – Health Services and Care Pathways

Category 2 – Health Technologies and Treatments

Share your initiatives that involve: the implementation of evidence-based guidelines for managing specific clinical condition(s); enhancements to operational efficiency (e.g. reducing wait times); use of communications and collaborations that improve care coordination/ transitions (e.g. interdisciplinary or across healthcare settings); care model/ service transformation; or innovative projects for quality and safety improvement.

Primary focus: Service delivery models and care pathway improvements

Key Requirement:

Demonstrates measurable improvements in clinical and/or patient outcomes; and includes measurement of implementation costs

Examples:

Integrated care models
End-to-end patient journey optimisation
Implementation of Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs)
Novel Value-Driven Care Approaches (e.g., ERAS)

Share your initiatives that demonstrate the positive impact of adopting clinically- and cost-effective health technologies (e.g. drugs, devices, diagnostics, interventions, or vaccines) to drive value-based care changes in healthcare delivery. Examples include prescribing behaviour to use only clinically effective and cost-effective health technologies.

Primary focus: Implementation and impact of specific healthcare technologies (e.g., drugs, medical devices, diagnostics, interventions, or vaccines)

Key Requirement:

Demonstrates the positive impact of adopting clinically- and cost-effective health technologies to improve healthcare delivery

Examples:

Changes in prescribing behaviour to adopt clinically- and cost-effective health technologies

Eligibility Criteria

Abstract authors and co-authors must be from Singapore's healthcare institutions or academic institutions.
The submitted abstract must not be an industry-funded research.
Submitted abstracts must contain data generated after 30 June 2024.
The submitting author/s are responsible for obtaining consent from all co-authors prior to submission.
By submitting an abstract, all authors consent to have the abstract title and presenter's name published in the MOH AVBC Conference 2025 proceedings if accepted.
Abstracts will only be accepted if at least one author can attend and present the abstract in-person at the MOH AVBC Conference 2025, if shortlisted.
Submitted abstracts should not have been previously published in journals or online publications.

Submission Guidelines

All abstracts must be written (and, if relevant, presented) in English.
Abstracts must not exceed 300 words.
Submissions should be concise and clearly include the following sections: Aim, Background, Methods, Results, and Conclusion.
Abstracts will be reproduced exactly as submitted—please proofread carefully.
Authors must ensure their submission aligns with and is under the most appropriate track.
Only abstracts submitted before the closing date will be considered.
Use generic drug names only. Proprietary names should be avoided unless no generic equivalent exists, and trademark or registered symbols should not be included.
Submissions that do not adhere to these guidelines may not be considered for presentation.